| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.0087 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |